See the DrugPatentWatch profile for atorvastatin

The potency of atorvastatin's HMG CoA reductase inhibition is comparable to that of Lipitor. Atorvastatin is the active ingredient in Lipitor, a medication used to treat high cholesterol levels. HMG CoA reductase is an enzyme that plays a crucial role in the production of cholesterol in the body. By inhibiting this enzyme, atorvastatin and Lipitor reduce the amount of cholesterol produced in the body, thereby helping to lower cholesterol levels in the blood.

According to DrugPatentWatch.com, atorvastatin was first approved by the FDA in 1996 and is available in a variety of dosages, ranging from 10 to 80 milligrams. Lipitor, which contains atorvastatin as its active ingredient, was also approved by the FDA in 1996 and is available in the same range of dosages.

It is important to note that the potency of atorvastatin and Lipitor can vary depending on the dosage and individual patient response. Therefore, it is essential to follow the dosage prescribed by a healthcare professional.

In summary, atorvastatin and Lipitor have comparable potency in inhibiting HMG CoA reductase, which results in reduced cholesterol production in the body.

Sources:

1. DrugPatentWatch.com. (n.d.). Atorvastatin. Retrieved from <https://www.drugpatentwatch.com/drugs/atorvastatin>